Heparin in Acute Ischemic Stroke: The Case for a New Clinical Trial

Publisher： Karger

E-ISSN： 1421-9786|9|3|16-23

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.9, Iss.3, 1999-07, pp. : 16-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Initial Safety Experience of Abciximab and Heparin for Acute Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 19, Iss. 4, 2005-04 ,pp. : 276-278

Karger

Access to resources Recommend Favorite

Associations of Clinical Stroke Misclassification (‘Clinical-Imaging Dissociation’) in Acute Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 29, Iss. 4, 2010-02 ,pp. : 395-402

Karger

Access to resources Recommend Favorite

Acute Ischemic Stroke and New Anticoagulants – How to Act in the Acute Phase of Stroke

By  

Cerebrovascular Diseases, Vol. 35, Iss. 1, 2013-02 ,pp. : 91-91

Karger

Access to resources Recommend Favorite

Clinical Presentation and Ischemic Zone on MRI in Cancer Patients with Acute Ischemic Stroke

By  

European Neurology, Vol. 68, Iss. 6, 2012-10 ,pp. : 368-376

Karger

Access to resources Recommend Favorite

Negative Interaction of Aspirin and Streptokinase in Acute Ischemic Stroke: Further Analysis of the Multicenter Acute Stroke Trial-Italy

By  

Cerebrovascular Diseases, Vol. 10, Iss. 1, 2000-01 ,pp. : 61-64

Karger

Access to resources Recommend Favorite